Product NewsClinical Diagnostics
Meaningful Use: The Lab's Role in Attesting Stage 2 and 3
15 Oct 2015
Liana F. Romero, PhD, MBA-GM, MT (ASCP), Senior Director of Strategic Development & Automation/IT at Siemens Healthcare Diagnostics, discusses meaningful use and healthcare reform and how the laboratory can attest MU2 and MU3.